Constitutive activation of NF‐κB and T‐cell leukemia/lymphoma in Notch3 transgenic mice
暂无分享,去创建一个
U. Lendahl | I. Screpanti | D. Bellavia | A. Hayday | L. Frati | A. Gulino | C. Gaetano | M. P. Felli | A. Stoppacciaro | E. S. Hoffman | E. Alesse | L. Ruco | M. Giovarelli | A. Vacca | C. Tiveron | L. Tatangelo | Anna Balestri | A. Campese
[1] I. Villey,et al. RORγT, a thymus‐specific isoform of the orphan nuclear receptor RORγ / TOR, is up‐regulated by signaling through the pre‐T cell receptor and binds to the TEA promoter , 1999, European journal of immunology.
[2] H. Pahl. Activators and target genes of Rel/NF-κB transcription factors , 1999, Oncogene.
[3] B. Rayet,et al. Aberrant rel/nfkb genes and activity in human cancer , 1999, Oncogene.
[4] U. Lendahl,et al. The notch 3 intracellular domain represses notch 1-mediated activation through Hairy/Enhancer of split (HES) promoters. , 1999, Development.
[5] J. Aster,et al. Notch1 expression in early lymphopoiesis influences B versus T lineage determination. , 1999, Immunity.
[6] David J. Anderson,et al. Notch signalling controls pancreatic cell differentiation , 1999, Nature.
[7] A Gulino,et al. Expression pattern of notch1, 2 and 3 and Jagged1 and 2 in lymphoid and stromal thymus components: distinct ligand-receptor interactions in intrathymic T cell development. , 1999, International immunology.
[8] N. Tarantino,et al. In Vivo Inhibition of NF-κB in T-Lineage Cells Leads to a Dramatic Decrease in Cell Proliferation and Cytokine Production and to Increased Cell Apoptosis in Response to Mitogenic Stimuli, But Not to Abnormal Thymopoiesis , 1999, The Journal of Immunology.
[9] K. Tomita,et al. The bHLH gene Hes1 is essential for expansion of early T cell precursors. , 1999, Genes & development.
[10] H. Macdonald,et al. Deficient T cell fate specification in mice with an induced inactivation of Notch1. , 1999, Immunity.
[11] S. Artavanis-Tsakonas,et al. Notch signaling: cell fate control and signal integration in development. , 1999, Science.
[12] M. Tomonaga,et al. Constitutive Activation of NF-κB in Primary Adult T-Cell Leukemia Cells , 1999 .
[13] J. Buer,et al. Pleiotropic changes controlled by the pre-T-cell receptor. , 1999, Current opinion in immunology.
[14] M. Tomonaga,et al. Constitutive Activation Of Nf- κ B In Primary Adult T-cell Leukemia Cells , 1999 .
[15] C. Jongeneel,et al. Impaired fetal thymocyte development after efficient adenovirus-mediated inhibition of NF-kappa B activation. , 1999, Journal of immunology.
[16] W. Zong,et al. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-κB that blocks TNFα-induced apoptosis , 1999 .
[17] M. Bevan,et al. Correlating notch signaling with thymocyte maturation. , 1998, Immunity.
[18] M. Bevan,et al. RORgamma t, a novel isoform of an orphan receptor, negatively regulates Fas ligand expression and IL-2 production in T cells. , 1998, Immunity.
[19] H. Macdonald,et al. The role of the T‐cell receptor (TCR) in αβ/γδ lineage commitment: clues from intracellular TCR staining , 1998, Immunological reviews.
[20] W. Greene,et al. Human T-Cell Leukemia Virus Type 1 Tax Induction of NF-κB Involves Activation of the IκB Kinase α (IKKα) and IKKβ Cellular Kinases , 1998, Molecular and Cellular Biology.
[21] D. F. Barber,et al. Cutting Edge: The Expression In Vivo of a Second Isoform of pTα: Implications for the Mechanism of pTα Action , 1998, The Journal of Immunology.
[22] A. Angelucci,et al. The growth arrest and downregulation of c-myc transcription induced by ceramide are related events dependent on p21 induction, Rb underphosphorylation and E2F sequestering , 1998, Cell Death and Differentiation.
[23] F. Oswald,et al. NF-κB2 Is a Putative Target Gene of Activated Notch-1 via RBP-Jκ , 1998, Molecular and Cellular Biology.
[24] M. Bevan,et al. T-cell selection. , 1998, Current opinion in immunology.
[25] M. Boothby,et al. Perturbation of the T Lymphocyte Lineage In Transgenic Mice Expressing a Constitutive Repressor of Nuclear Factor (NF)-κB , 1997, The Journal of experimental medicine.
[26] B. Fowlkes,et al. Notch Activity Influences the αβ versus γδ T Cell Lineage Decision , 1997, Cell.
[27] G. Weinmaster,et al. An Activated Form of Notch Influences the Choice between CD4 and CD8 T Cell Lineages , 1996, Cell.
[28] Seamus J. Martin,et al. Suppression of TNF-α-Induced Apoptosis by NF-κB , 1996, Science.
[29] U. Lendahl,et al. Expression of the Notch 3 intracellular domain in mouse central nervous system progenitor cells is lethal and leads to disturbed neural tube development , 1996, Mechanisms of Development.
[30] I. Screpanti,et al. Expression of trKB neurotrophin receptor during T cell development. Role of brain derived neurotrophic factor in immature thymocyte survival. , 1996, Journal of immunology.
[31] D. Carrasco,et al. The v‐rel oncogene promotes malignant T‐cell leukemia/lymphoma in transgenic mice. , 1996, The EMBO journal.
[32] J. Sklar,et al. Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles , 1996, The Journal of experimental medicine.
[33] J. Laborda,et al. T cell leukemia-associated human Notch/translocation-associated Notch homologue has I kappa B-like activity and physically interacts with nuclear factor-kappa B proteins in T cells , 1996, The Journal of experimental medicine.
[34] D. Schatz,et al. Productive T-cell receptor beta-chain gene rearrangement: coincident regulation of cell cycle and clonality during development in vivo. , 1996, Genes & development.
[35] F. Bach,et al. Inhibition of endothelial cell activation by adenovirus-mediated expression of I kappa B alpha, an inhibitor of the transcription factor NF-kappa B , 1996, The Journal of experimental medicine.
[36] A. Passaniti,et al. VEGF165 expressed by a replication-deficient recombinant adenovirus vector induces angiogenesis in vivo. , 1995, Circulation research.
[37] A. Israël. A role for phosphorylation and degradation in the control of NF-κB activity , 1995 .
[38] I. Screpanti,et al. Positive and negative regulation of the composite octamer motif of the interleukin 2 enhancer by AP-1, Oct-2, and retinoic acid receptor , 1994, The Journal of experimental medicine.
[39] H. Macdonald,et al. Double‐negative thymocyte subsets in CD3′ chain‐deficient mice: Absence of HSA+CD44−CD25− cells , 1994, European journal of immunology.
[40] M J Owen,et al. T cell receptor beta chain gene rearrangement and selection during thymocyte development in adult mice. , 1994, Immunity.
[41] V. Bours,et al. The oncoprotein Bcl‐3 can facilitate NF‐kappa B‐mediated transactivation by removing inhibiting p50 homodimers from select kappa B sites. , 1993, The EMBO journal.
[42] M. Lenardo,et al. Gene transcription in differentiating immature T cell receptor(neg) thymocytes resembles antigen-activated mature T cells , 1993, The Journal of experimental medicine.
[43] A. Zlotnik,et al. A developmental pathway involving four phenotypically and functionally distinct subsets of CD3-CD4-CD8- triple-negative adult mouse thymocytes defined by CD44 and CD25 expression. , 1993, Journal of immunology.
[44] V. Bours,et al. The candidate oncoprotein Bcl-3 is an antagonist of pSO/NF-κB-mediated inhibition , 1992, Nature.
[45] J. Sklar,et al. TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms , 1991, Cell.
[46] R. Boyd,et al. Towards an integrated view of thymopoiesis. , 1991, Immunology today.
[47] R. Perlmutter,et al. Dissection of thymocyte signaling pathways by in vivo expression of pertussis toxin ADP‐ribosyltransferase. , 1990, The EMBO journal.
[48] E. Jenkinson,et al. Importance of IL-2 receptors in intra-thymic generation of cells expressing T-cell receptors , 1987, Nature.
[49] B. Fowlkes,et al. Notch Activity Influences the a versus ?d T Cell Lineage Decision , 1997 .